Litcius/Paper detail

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Emma Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, Rodney S. Daniels, Lorin Adams, Philip Hobson, Emine Hatipoglu, Yenting Ngai, Saira Hussain, Karen Ambrose, Steve Hindmarsh, Rupert Beale, Andrew Riddell, Steve Gamblin, Michael Howell, George Kassiotis, Vincenzo Libri, Bryan Williams, Charles Swanton, Sonia Gandhi, David L.V. Bauer

2021The Lancet135 citationsDOIOpen Access PDF

Topics & Concepts

UploadGovernment (linguistics)Coronavirus disease 2019 (COVID-19)VaccinationMedicinePublishingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicPublic healthBusinessVirologyPolitical scienceNursingWorld Wide WebComputer scienceInfectious disease (medical specialty)LinguisticsPhilosophyPathologyLawDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC | Litcius